We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Fields »
 

Field

Term
Gene name

Class

Subclass

Chromosome

External id

In atlas

Reliability

Reliability

Reliability

Validation

Method

Validation

Method

Validation

Method

Validation

Location

Searches

Tissue

Cell type

Expression

Tissue

Specificity

Cell line

Specificity

Cancer

Specificity

Tissue

Detectable

Cell line

Detectable

Cancer

Detectable

Cancer

Prognosis

Category

Score

Score

Score

Antibodies

Column

 
 
ABOUT
HELP
BLOG
  • THE HUMAN PROTEOME
  • THE HUMAN TISSUES
  • THE HUMAN CELL
  • HUMAN PATHOLOGY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
    • NEWS
    • BLOG
    • EVENTS
    • PRESS ROOM
    • LEARN
    • DICTIONARY
    • METHODS
    • CELL LINES
  • THE PROJECT
  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • PUBLICATION DATA
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • LINKS
  • CONTACT
  • TECHNICAL DATA
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • DOWNLOADABLE DATA
  • HELP & FAQ
  • LICENCE & CITATION
  • PRIVACY STATEMENT
  • RELEASE HISTORY
MYL2
  • premium

    TISSUE

  • CELL

  • PATHOLOGY

PATHOLOGY ATLAS

GENE/PROTEIN

Antibody validation

Dictionary

Level of antibody staining/expression





High
Medium
Low
Not detected

GENERAL INFORMATION

Gene name

MYL2

Gene description

Myosin, light chain 2, regulatory, cardiac, slow

Protein class

Candidate cardiovascular disease genes
Disease related genes
Predicted intracellular proteins

Predicted localization

Intracellular

Number of transcripts

2
SHOW MORE

HUMAN PROTEIN ATLAS INFORMATION

RNA category

TCGA (cancer tissue):Group enriched (head and neck cancer, prostate cancer)
HPA (cell line):Group enriched (EFO-21, U-2 OS)
HPA (normal tissue):Group enriched (heart muscle, skeletal muscle)

Protein evidence

Evidence at protein level

Protein expression
normal tissue

Selective cytoplasmic expression in heart and skeletal muscle.

ANTIBODY IHC RELIABILITY

Data reliability
description

Antibody staining mainly consistent with RNA expression data. Caution, targets protein from more than one gene. Presumed off target binding observed and disregarded.

Reliability score

Supported based on 2 antibodies.
HPA019763 , HPA039262
SHOW MORE

PROGNOSTIC SUMMARY

Prognostic marker in head and neck cancer (unfavourable).
Head and neck cancer p<0.001
Show all

RNA EXPRESSION OVERVIEW

TCGA dataset
RNA cancer category: Group enriched (head and neck cancer, prostate cancer)

PROTEIN EXPRESSION

Colorectal cancer
Breast cancer
Prostate cancer
Lung cancer
Liver cancer

STAINING SUMMARY

HPA019763
HPA039262

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

A subset of tumor cells in few cases of glioma showed moderate to strong cytoplasmic positivity. Several cases of squamous cell carcinomas of lung and few cases of melanoma along with papillary adenocarcinomas of thyroid displayed moderate staining. Few cases of testis, endometrial and pancreatic cancers showed membranous immunoreactivity. Remaining cancer tissues were weakly stained or negative.

Cancer

Cancer staining

Protein
expression of
normal tissue

Breast cancer
 
Carcinoid
 
Cervical cancer
 
 
Colorectal cancer
 
 
Endometrial cancer
 
 
Glioma
 
Head and neck cancer
 
 
Liver cancer
 
 
Lung cancer
 
 
Lymphoma
 
 

Cancer

Cancer staining

Protein
expression of
normal tissue

Melanoma
 
Ovarian cancer
 
Pancreatic cancer
 
Prostate cancer
 
Renal cancer
 
Skin cancer
 
Stomach cancer
 
 
Testis cancer
 
Thyroid cancer
 
Urothelial cancer
 

Staining summary

Few cases of colorectal, endometrial and hepatocellular carcinomas displayed weak to moderate membranous positivity. Remaining cancer tissues were negative.

GENE INFORMATION

Gene name

MYL2 (HGNC Symbol)

Synonyms

CMH10

Description

Myosin, light chain 2, regulatory, cardiac, slow (HGNC Symbol)

Entrez gene summary

Thus gene encodes the regulatory light chain associated with cardiac myosin beta (or slow) heavy chain. Ca+ triggers the phosphorylation of regulatory light chain that in turn triggers contraction. Mutations in this gene are associated with mid-left ventricular chamber type hypertrophic cardiomyopathy. [provided by RefSeq, Jul 2008]

Chromosome

12

Cytoband

q24.11

Chromosome location (bp)

110910819 - 110920722

Protein evidence

Evidence at protein level (all genes)

Ensembl

ENSG00000111245 (version 83.38)

Entrez gene

4633

UniProt

P10916 (UniProt - Evidence at protein level)

neXtProt

NX_P10916

Antibodypedia

MYL2 antibodies

PROTEIN BROWSER

MYL2-001
MYL2-006

PROTEIN INFORMATION

Splice variant

UniProt

Protein class

Gene ontology

Length & mass

Signal peptide
(predicted)

Transmembrane regions
(predicted)

MYL2-001
ENSP00000228841
ENST00000228841
P10916 [Direct mapping]
Myosin regulatory light chain 2, ventricular/cardiac muscle isoform
Q6IB42 [Target identity:100%; Query identity:100%]
MYL2 protein; Myosin, light polypeptide 2, regulatory, cardiac, slow, isoform CRA_a; cDNA, FLJ92288, highly similar to Homo sapiens myosin, light polypeptide 2, regulatory, cardiac, slow (MYL2), mRNA
Show all
Predicted intracellular proteins
Candidate cardiovascular disease genes
Disease related genes
Protein evidence (Kim et al 2014)
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0002026 [regulation of the force of heart contraction]
GO:0003007 [heart morphogenesis]
GO:0003785 [actin monomer binding]
GO:0005509 [calcium ion binding]
GO:0005515 [protein binding]
GO:0005829 [cytosol]
GO:0005856 [cytoskeleton]
GO:0006942 [regulation of striated muscle contraction]
GO:0007507 [heart development]
GO:0008307 [structural constituent of muscle]
GO:0009791 [post-embryonic development]
GO:0015629 [actin cytoskeleton]
GO:0016459 [myosin complex]
GO:0030016 [myofibril]
GO:0030017 [sarcomere]
GO:0030049 [muscle filament sliding]
GO:0030308 [negative regulation of cell growth]
GO:0031672 [A band]
GO:0032036 [myosin heavy chain binding]
GO:0042694 [muscle cell fate specification]
GO:0048747 [muscle fiber development]
GO:0055003 [cardiac myofibril assembly]
GO:0055010 [ventricular cardiac muscle tissue morphogenesis]
GO:0060047 [heart contraction]
GO:0060048 [cardiac muscle contraction]
GO:0098735 [positive regulation of the force of heart contraction]
Show all
166 aa
18.8 kDa
No 0
MYL2-006
ENSP00000447154
ENST00000548438
G3V1V8 [Direct mapping]
Myosin regulatory light chain 2, ventricular/cardiac muscle isoform; Myosin, light polypeptide 2, regulatory, cardiac, slow, isoform CRA_b
Show all
Predicted intracellular proteins
Protein evidence (Ezkurdia et al 2014)
Show all
GO:0005509 [calcium ion binding]
Show all
152 aa
17.1 kDa
No 0

Contact

  • BLOG
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS
  • DOWNLOADABLE DATA

The Human Protein Atlas

  • ANTIBODY AVAILABILITY
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.